TELA

TELA

USD

TELA Bio Inc. Common Stock

$1.870-0.050 (-2.604%)

Reaalajas hind

Healthcare
Meditsiiniseadmed
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.920

Kõrge

$2.050

Madal

$1.860

Maht

0.07M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

74.0M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

0.27M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $0.865Praegune $1.870Kõrge $5.6

Seotud uudised

GlobeNewswire

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that

Vaata rohkem
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the

Vaata rohkem
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
GlobeNewswire

TELA Bio Appoints Jeffrey Blizard as President

MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the

Vaata rohkem
TELA Bio Appoints Jeffrey Blizard as President
GlobeNewswire

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ:TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the

Vaata rohkem
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.